Why is Indo US Bio-Tech falling/rising?

As of 23-Jul, Indo US Bio-Tech Ltd is experiencing a decline in its stock price, currently at Rs 177.60, which represents a decrease of Rs 9.3 or 4.98%. The stock has underperformed its sector by 5.55% today and has been on a consecutive downward trend for the last two days, with a total drop of 10.93% during this period. Despite a strong performance over the past week and month, with returns of 12.58% and 18.60% respectively, the stock has significantly underperformed over the year, showing a decline of 18.90%. Positive factors such as high management efficiency, a strong ability to service debt, and healthy long-term growth in operating profit and net sales have not been enough to counteract the negative sentiment surrounding the stock, particularly its expensive valuation and recent underperformance relative to the broader market.
In the broader market context, while the Sensex has shown a modest increase of 0.11% over the past week, Indo US Bio-Tech's recent performance indicates a stark contrast, especially given its year-to-date decline of 43.62% compared to the Sensex's gain of 5.87%. The stock's negative returns over the past year highlight its struggle to keep pace with the market, which has generated a return of 1.79%. This underperformance, coupled with the stock's high valuation metrics and recent price movements, suggests that investor sentiment may be cautious, leading to the current decline in its stock price.